• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

NHS England invites 75-80-year-olds for their first respiratory syncytial virus (RSV) vaccines - why should not those in their 80s be included too?

作者信息

Merchant Hamid A

机构信息

Department of Bioscience, School of Health, Sport and Bioscience, University of East London, London, UK.

出版信息

J Pharm Policy Pract. 2025 Mar 19;18(1):2477761. doi: 10.1080/20523211.2025.2477761. eCollection 2025.

DOI:10.1080/20523211.2025.2477761
PMID:40115540
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11924248/
Abstract
摘要

相似文献

1
NHS England invites 75-80-year-olds for their first respiratory syncytial virus (RSV) vaccines - why should not those in their 80s be included too?英国国家医疗服务体系（NHS）邀请75至80岁的人群接种首剂呼吸道合胞病毒（RSV）疫苗——那为什么不把80多岁的人也包括在内呢？
J Pharm Policy Pract. 2025 Mar 19;18(1):2477761. doi: 10.1080/20523211.2025.2477761. eCollection 2025.
2
Noninferior Immunogenicity and Consistent Safety of Respiratory Syncytial Virus Prefusion F Protein Vaccine in Adults 50-59 Years Compared to ≥60 Years of Age.50-59 岁成年人与≥60 岁老年人相比，呼吸道合胞病毒融合前 F 蛋白疫苗具有非劣效免疫原性和一致安全性。
Clin Infect Dis. 2024 Oct 15;79(4):1074-1084. doi: 10.1093/cid/ciae364.
3
Estimating the burden of respiratory syncytial virus (RSV) on respiratory hospital admissions in children less than five years of age in England, 2007-2012.估算2007 - 2012年呼吸道合胞病毒（RSV）对英格兰5岁以下儿童因呼吸道疾病住院治疗的负担。
Influenza Other Respir Viruses. 2017 Mar;11(2):122-129. doi: 10.1111/irv.12443. Epub 2017 Jan 21.
4
Respiratory Syncytial Virus Prefusion F Vaccination: Antibody Persistence and Revaccination.呼吸道合胞病毒融合前 F 疫苗接种：抗体持久性和再次接种。
J Infect Dis. 2024 Oct 16;230(4):e905-e916. doi: 10.1093/infdis/jiae185.
5
Immunogenicity and Safety Following 1 Dose of AS01E-Adjuvanted Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults: A Phase 3 Trial.AS01E 佐剂呼吸道合胞病毒融合前 F 蛋白疫苗在老年人中接种 1 剂后的免疫原性和安全性：一项 3 期试验。
J Infect Dis. 2024 Jul 25;230(1):e102-e110. doi: 10.1093/infdis/jiad546.
6
Developing influenza and respiratory syncytial virus activity thresholds for syndromic surveillance in England.制定英格兰综合征监测中流感和呼吸道合胞病毒活动阈值。
Epidemiol Infect. 2019 Jan;147:e163. doi: 10.1017/S0950268819000542.
7
The immunogenicity and safety of respiratory syncytial virus vaccines in development: A systematic review.正在研发中的呼吸道合胞病毒疫苗的免疫原性和安全性：系统评价。
Influenza Other Respir Viruses. 2021 Jul;15(4):539-551. doi: 10.1111/irv.12850. Epub 2021 Mar 25.
8
Epidemiology of respiratory syncytial virus in children younger than 5 years in England during the COVID-19 pandemic, measured by laboratory, clinical, and syndromic surveillance: a retrospective observational study.在 COVID-19 大流行期间，通过实验室、临床和综合征监测测量英格兰 5 岁以下儿童呼吸道合胞病毒的流行病学：一项回顾性观察研究。
Lancet Infect Dis. 2023 Jan;23(1):56-66. doi: 10.1016/S1473-3099(22)00525-4. Epub 2022 Sep 2.
9
Efficacy and Safety of Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults Over 2 RSV Seasons.呼吸道合胞病毒（RSV）预融合F蛋白疫苗（RSVPreF3 OA）在两个RSV流行季节对老年人的疗效和安全性
Clin Infect Dis. 2024 Jun 14;78(6):1732-1744. doi: 10.1093/cid/ciae010.
10
Epidemiology, clinical features, and resource utilization associated with respiratory syncytial virus in the community and hospital.呼吸道合胞病毒在社区和医院中的流行病学、临床特征和资源利用情况。
Influenza Other Respir Viruses. 2020 May;14(3):247-256. doi: 10.1111/irv.12723. Epub 2020 Feb 20.

本文引用的文献

1
Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older Adults.一种二价呼吸道合胞病毒预融合F疫苗在老年人中的疗效和安全性
N Engl J Med. 2023 Apr 20;388(16):1465-1477. doi: 10.1056/NEJMoa2213836. Epub 2023 Apr 5.
2
Modelling estimates of the burden of Respiratory Syncytial virus infection in adults and the elderly in the United Kingdom.英国成人和老年人呼吸道合胞病毒感染负担的建模估计
BMC Infect Dis. 2015 Oct 23;15:443. doi: 10.1186/s12879-015-1218-z.
3
Mortality caused by influenza and respiratory syncytial virus by age group in England and Wales 1999-2010.1999-2010 年英格兰和威尔士按年龄组划分的流感和呼吸道合胞病毒导致的死亡率。
Influenza Other Respir Viruses. 2013 Jan;7(1):35-45. doi: 10.1111/j.1750-2659.2012.00345.x. Epub 2012 Mar 9.